Akoya Biosciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Akoya Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
  • Akoya Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$10.5M, a 18.5% increase year-over-year.
  • Akoya Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$58M, a 18.8% increase year-over-year.
  • Akoya Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$63.3M, a 10.4% increase from 2022.
  • Akoya Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$70.6M, a 64.5% decline from 2021.
  • Akoya Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$42.9M, a 157% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$58M -$10.5M +$2.38M +18.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$60.4M -$13.1M +$7.65M +36.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$68M -$23.5M -$4.68M -24.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q4 2023 -$63.3M -$10.8M +$8.07M +42.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$71.4M -$12.9M +$4.96M +27.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$76.4M -$20.8M -$3.31M -18.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$73M -$18.8M -$2.4M -14.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$70.6M -$18.9M -$1.2M -6.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$69.4M -$17.9M -$6.26M -53.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$63.2M -$17.5M -$11.9M -214% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$51.3M -$16.4M -$8.32M -103% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$42.9M -$17.7M -$12M -210% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 -$31M -$11.6M -$7.33M -171% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$23.6M -$5.56M -$978K -21.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$22.6M -$8.08M -$5.94M -277% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$16.7M -$5.69M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$4.28M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$4.59M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-09
Q1 2020 -$2.14M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.